MRNA 全部观点

And speaking of healthcare, Stefan was asking earlier about Madna, which obviously had the huge cancer vaccine news. Here's a look at the chart 13. I know we're running out of time, but to me, this really kind of needs to hold 130. 1301 120. If it holds these two areas, we still have room in this God candle that we're still inside to the upside. But if we end up coughing this up, I think we are looking at a nasty gap fill below.

So then uh you've got Mona coming down again a little bit here. another 8%. There is a lot of trading volume in this. So, it's not uncommon to see some of this juice come out. This is a very very normal kind of post enthusiasm bleed out. Uh, and I'm very curious to see if it stabilizes at 126 or if it keeps going down. Uh, could be some opportunities there. Obviously, the company still loses money, but massive hope and it's not really a cancer vaccine. I know people call it a cancer vaccine, but it's more of um a cancer therapy that they're working on, which which is also very important. Um in fact, um I mean, while a vaccine would be cool, I think this is more of a first stage.